Regulation of insulin-like growth factor receptors by Ubiquilin1
- 6 December 2017
- journal article
- research article
- Published by Portland Press Ltd. in Biochemical Journal
- Vol. 474 (24), 4105-4118
- https://doi.org/10.1042/bcj20170620
Abstract
Insulin-like growth factor-1 receptor (IGF1R) is a receptor tyrosine kinase that mediates growth, proliferation and survival. Dysregulation of IGF pathway contributes to the initiation, progression and metastasis of cancer and is also involved in diseases of glucose metabolism, such as diabetes. We have identified Ubiquilin1 (UBQLN1) as a novel interaction partner of IGF1R, IGF2R and insulin receptor (INSR). UBQLN family of proteins have been studied primarily in the context of protein quality control and in the field of neurodegenerative disorders. Our laboratory discovered a link between UBQLN1 function and tumorigenesis, such that UBQLN1 is lost and underexpressed in 50% of human lung adenocarcinoma cases. We demonstrate here that UBQLN1 regulates the expression and activity of IGF1R. Following loss of UBQLN1 in lung adenocarcinoma cells, there is accelerated loss of IGF1R. Despite decreased levels of total receptors, the ratio of active : total receptors is higher in cells that lack UBQLN1. UBQLN1 also regulates INSR and IGF2R post-stimulation with ligand. We conclude that UBQLN1 is essential for normal regulation of IGF receptors. UBQLN-1-deficient cells demonstrate increased cell viability compared with control when serum-starved and stimulation of IGF pathway in these cells increased their migratory potential by 3-fold. As the IGF pathway is involved in processes of normal growth, development, metabolism and cancer progression, understanding its regulation by Ubiquilin1 can be of tremendous value to many disciplines.This publication has 39 references indexed in Scilit:
- The Insulin/IGF System in Colorectal Cancer Development and Resistance to TherapyFrontiers in Oncology, 2015
- Ubiquitination, localization, and stability of an anti-apoptotic BCL2-like protein, BCL2L10/BCLb, are regulated by Ubiquilin1Proceedings of the National Academy of Sciences of the United States of America, 2012
- The Ubiquitin-like Protein PLIC-2 Is a Negative Regulator of G Protein-coupled Receptor EndocytosisMolecular Biology of the Cell, 2008
- The Adapter Protein GRB10 Is an Endogenous Negative Regulator of Insulin-Like Growth Factor SignalingEndocrinology, 2005
- Distinct Grb10 domain requirements for effects on glucose uptake and insulin signalingMolecular and Cellular Endocrinology, 2005
- Overexpression of ubiquilin decreases ubiquitination and degradation of presenilin proteinsJournal of Alzheimer's Disease, 2004
- Negative Regulation of Insulin-Stimulated Mitogen-Activated Protein Kinase Signaling By Grb10Molecular Endocrinology, 2004
- GABAA receptor cell surface number and subunit stability are regulated by the ubiquitin-like protein Plic-1Nature Neuroscience, 2001
- Up-regulation of urokinase-type plasminogen activator by insulin-like growth factor-I depends upon phosphatidylinositol-3 kinase and mitogen-activated protein kinase kinase.2001
- Insulin like growth factor-1 selectively regulates the expression of matrix metalloproteinase-2 in malignant H-ras transformed cells.Molecular and Cellular Biochemistry, 2001